Tessa L Holyoake

Tessa L Holyoake

Professor of Experimental Haematology, Institute of Cancer Sciences, University of Glasgow
Verified email at glasgow.ac.uk
Cited by 33021
CML stem cell biology
Andrew C. W. Zannettino

Andrew CW Zannettino

University of Adelaide
Verified email at adelaide.edu.au
Cited by 22012
haematology myeloma mesenchymal stem cells cml all
Steve O'Brien

Steve O'Brien

Professor of Haematology
Verified email at steve7233.org
Cited by 10720
CML
Jeroen Janssen

Jeroen Janssen

assistant-professor, Dept of Hematology, Cancer Center Amsterdam, Amsterdam University …
Verified email at amsterdamumc.nl
Cited by 8040
Hematology AML CML
Juan Carlos Hernandez-Boluda

Juan Carlos Hernandez-Boluda

Hematology Department, Hospital Clínico Universitario de Valencia, Spain
Cited by 6848
MPN CML
David Ross

David Ross

SAHMRI and Centre for Cancer Biology
Verified email at sa.gov.au
Cited by 6456
CML MPN myeloid neoplasia
Athina Giannoudis

Athina Giannoudis

Dr, University of Liverpool
Verified email at liverpool.ac.uk
Cited by 4349
Breast Cancer Pharmacogenetics Drug transporters Molecular biology CML
David Yeung

David Yeung

Precision Medicine, SAHMRI, Adelaide
Verified email at adelaide.edu.au
Cited by 4146
CML ALL BMT
Heather G Jørgensen

Heather G Jørgensen

Senior Research Fellow, Institute of Cancer Sciences, University of Glasgow
Verified email at glasgow.ac.uk
Cited by 4028
Myeloid malignancy stem cells CML nanoparticles
S.Tiong Ong

S.Tiong Ong

Duke-NUS Medical School
Verified email at duke-nus.edu.sg
Cited by 3458
Targeted therapies drug resistance biomarkers genomics CML
1 - 10